Cases & Investigations

Xarelto Class Action Lawsuit Investigation

PRODUCT: Xarelto
CASE STATUS: Under Investigation

The attorneys at Berger Montague are reviewing claims on behalf of patients who took Xarelto, a blood-thinning drug that has been linked to hundreds of serious injuries and deaths.  If you or a loved one suffered a serious bleeding event after taking Xarelto, call Berger Montague to speak to an attorney today, free of charge.

What is Xarelto and Why is it Dangerous?

Xarelto is an anticoagulant, or blood thinner, prescribed to patients who have recently undergone knee or hip surgery and to prevent clots in patients suffering from:

  • Atrial fibrillation (irregular heart beat);
  • Deep vein thrombosis (blood clots deep within the body); and
  • Pulmonary embolism (blood clots in the lungs).

Patients who have taken Xarelto have suffered serious side effects and complications, including:

  • Uncontrollable bleeding;
  • Gastrointestinal and other internal bleeding, including cerebral hemorrhage (bleeding in the brain); and
  • Blood clots, which sometimes lead to stroke.

Xarelto is a particularly dangerous blood thinner because it has no known antidote, meaning it is very difficult for doctors to stop internal bleeding or prevent potentially-fatal blood loss in the event of a traumatic accident or emergency surgery.

Do you have a Xarelto claim? Talk to our Defective Drugs Attorneys.

Patients across the country are filing Xarelto lawsuits seeking compensation for past and future medical bills, lost wages, pain and suffering, and in cases of death of a loved one, funeral expenses.  If you or a loved one have taken Xarelto and have suffered an injury, do not hesitate to contact Berger Montague to speak with an attorney.  Either call us at (215) 875-3015, or fill out the form on the right to have an attorney contact you.

Lead Attorneys

Shanon J. Carson Headshot

Shanon J. Carson

Managing Shareholder

Request A Free Consultation

  • This field is for validation purposes and should be left unchanged.